Schedule 13G ownership disclosure
Taysha Gene Therapies Inc
Common Stock · CUSIP: 877619106
Event date: 2025-12-31
- Filing-level shares
- 17,852,291
- Percent of class
- 6.5%
- BlackRock, Inc.
Shares: 17,852,291 · Class: 6.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-26-000794
- Form type
- SCHEDULE 13G/A
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Jan 21, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership